Provided by Tiger Fintech (Singapore) Pte. Ltd.

Serina Therapeutics, Inc.

5.94
-0.2000-3.26%
Post-market: 5.940.00000.00%15:16 EDT
Volume:1.15K
Turnover:6.94K
Market Cap:59.21M
PE:-57.57
High:6.13
Open:5.89
Low:5.89
Close:6.14
Loading ...

Randall Moreadith, Chief Scientific Officer, Reports Disposal of Common Shares of Serina Therapeutics Inc

Reuters
·
02 Jul

SOL Strategies launches reserve for Solana tokens, with initial 52,181 JTO

cryptonews
·
27 Jun

SOL Strategies has announced the establishment of a Strategic Ecosystem Reserve, with a current holding of 52,181.564 JTO tokens.

Blockbeats
·
26 Jun

Updated: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership With M42

THOMSON REUTERS
·
18 Jun

Serina Therapeutics Inc. Files Initial Statement of Beneficial Ownership; Stephen K. Brannan Listed as Director

Reuters
·
18 Jun

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership With M42

THOMSON REUTERS
·
17 Jun

ETH Reserve War: Ethereum's Next Narrative Battle

Blockbeats
·
06 Jun

Serina Therapeutics Appoints Stephen Brannan, M.d. to Board of Directors

THOMSON REUTERS
·
23 May

Serina Therapeutics Announces Board Changes: Welcomes Dr. Stephen Brannan, Bids Farewell to Remy Gross

Reuters
·
23 May

Ethereum’s Strategic Reserve Set to Surge to 10 Million ETH by 2026, Experts Predict

BE[IN]CRYPTO
·
14 May

Serina Therapeutics Reports Q1 2025 Net Loss of $4.8M, EPS Improves to $(0.49) from $(5.38)

Reuters
·
09 May

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

GlobeNewswire
·
29 Apr

Serina Therapeutics : May Offer and Sell Shares of Common Stock of up to $13.3 Mln From Time to Time

THOMSON REUTERS
·
28 Apr

Serina Therapeutics Inc: Files for Offering of 5,593,972 Shares of Common Stock

THOMSON REUTERS
·
18 Apr

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit

GlobeNewswire
·
15 Apr

BRIEF-Serina Therapeutics Secures $5 Million Funding

Reuters
·
09 Apr

Serina Therapeutics Raises $5 Million for Clinical Development of Parkinson's Drug

MT Newswires Live
·
09 Apr

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of Ser-252 Into Clinical Development in Advanced Parkinson's Disease

THOMSON REUTERS
·
09 Apr

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease

GlobeNewswire
·
09 Apr

BRIEF-Serina Therapeutics Files For Mixed Shelf Of Upto $100 Million - SEC Filing

Reuters
·
03 Apr